CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 2151-2158

http://dx.doi.org/10.1351/pac200375112151

Use of NOAEL, benchmark dose, and other models for human risk assessment of hormonally active substances

R. W. Setzer, Jr. and C. A. Kimmel

USEPA, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Experimental Toxicology Division, Pharmacokinetics Branch, MD B143-01 109 TW Alexander Drive,Research Triangle Park, NC 27711, USA;

USEPA Office of Research and Development, National Center for Environmental Assessment (8623D), Ariel Rios Building, 1200 Pennsylvania Ave. NW, Washington, DC 20460, USA

CrossRef Cited-by theme picture

CrossRef Cited-by Linking

  • Greish Sarah, Ismail Saad M., Mosleh Yahia, Loutfy Naglaa, Dessouki Amina Ali, Ahmed Mohamed Tawfic: Human Risk Assessment of Profenofos: A Case Study in Ismailia, Egypt. GPOL 2011, 31, 28. <http://dx.doi.org/10.1080/10406638.2011.545727>
  • Sand Salomon, Victorin Katarina, Filipsson Agneta Falk: The current state of knowledge on the use of the benchmark dose concept in risk assessment. J Appl Toxicol 2008, 28, 405. <http://dx.doi.org/10.1002/jat.1298>
  • Stevenson R. Jan, Hill Brian H., Herlihy Alan T., Yuan Lester L., Norton Susan B.: Algae–P relationships, thresholds, and frequency distributions guide nutrient criterion development. J N am Benthol Soc 2008, 27, 783. <http://dx.doi.org/10.1899/07-077.1>
  • Manini Paola, De Palma Giuseppe, Mutti Antonio: Exposure assessment at the workplace: Implications of biological variability. Toxicol Lett 2007, 168, 210. <http://dx.doi.org/10.1016/j.toxlet.2006.09.014>